GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 82 filers reported holding GALENA BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,000 | -15.4% | 30,125 | +4.3% | 0.00% | – |
| Q2 2016 | $13,000 | -93.5% | 28,875 | -80.5% | 0.00% | -100.0% |
| Q1 2016 | $201,000 | -10.7% | 147,875 | -3.6% | 0.00% | 0.0% |
| Q4 2015 | $225,000 | -7.8% | 153,375 | -0.6% | 0.00% | -20.0% |
| Q3 2015 | $244,000 | -6.5% | 154,369 | +0.5% | 0.01% | 0.0% |
| Q2 2015 | $261,000 | +32.5% | 153,575 | +8.5% | 0.01% | +25.0% |
| Q1 2015 | $197,000 | -7.9% | 141,575 | -0.0% | 0.00% | -20.0% |
| Q4 2014 | $214,000 | +262.7% | 141,617 | +395.6% | 0.01% | +150.0% |
| Q3 2014 | $59,000 | -43.3% | 28,575 | -15.3% | 0.00% | -33.3% |
| Q2 2014 | $104,000 | +10.6% | 33,748 | -10.6% | 0.00% | 0.0% |
| Q1 2014 | $94,000 | -39.7% | 37,748 | +20.2% | 0.00% | -40.0% |
| Q4 2013 | $156,000 | +95.0% | 31,398 | -9.8% | 0.01% | +66.7% |
| Q3 2013 | $80,000 | +19.4% | 34,798 | +14.9% | 0.00% | +50.0% |
| Q2 2013 | $67,000 | – | 30,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |